Quick Answer
Niacinamide Skin Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: After 112-day use of REGENMEDIC cream and serum, test group showed increased skin elasticity and firmness, reduced wrinkles, and an overall improvement in skin tone and texture.
Key Takeaways
- 01After 112-day use of REGENMEDIC cream and serum, test group showed increased skin elasticity and firmness, reduced wrinkles, and an overall improvement in skin tone and texture. [Liu H (2026)]
- 02Pro-Xylane is a potent anti-aging ingredient; however, there is limited knowledge regarding whether a comprehensive post-procedure regimen incorporating a combination of Pro-Xylane, niacinamide, and panthenol alongside other active agents can deliver synergistic benefits for both skin barrier repair and anti-aging. [Liu H (2026)]
- 03This study assesses the effectiveness of the REGENMEDIC cream (anti-aging cream) and REGENMEDIC serum (anti-aging serum) in promoting skin barrier recovery and enhancing anti-aging effects following PicoWay laser treatment. [Liu H (2026)]
- 04The aim is to provide a mechanistically grounded and evidence‐oriented resource for researchers, dermatologists, and cosmetic scientists while distinguishing established clinical evidence from promising but still experimental approaches. [Chen Yuanyuan (2026)]
The current Migaku evidence database contains 2 reusable source documents for Niacinamide Skin Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- After 112-day use of REGENMEDIC cream and serum, test group showed increased skin elasticity and firmness, reduced wrinkles, and an overall improvement in skin tone and texture. [Liu H (2026); evidence level 2]
- Pro-Xylane is a potent anti-aging ingredient; however, there is limited knowledge regarding whether a comprehensive post-procedure regimen incorporating a combination of Pro-Xylane, niacinamide, and panthenol alongside other active agents can deliver synergistic benefits for both skin barrier repair and anti-aging. [Liu H (2026); evidence level 2]
- This study assesses the effectiveness of the REGENMEDIC cream (anti-aging cream) and REGENMEDIC serum (anti-aging serum) in promoting skin barrier recovery and enhancing anti-aging effects following PicoWay laser treatment. [Liu H (2026); evidence level 2]
- The aim is to provide a mechanistically grounded and evidence‐oriented resource for researchers, dermatologists, and cosmetic scientists while distinguishing established clinical evidence from promising but still experimental approaches. [Chen Yuanyuan (2026); evidence level 3]
- A third type, neuromelanin, is found in specific brain regions but has limited relevance to skin pigmentation []. [Chen Yuanyuan (2026); evidence level 3]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources